Advisors Asset Management Inc. grew its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 42.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 348,989 shares of the medical instruments supplier’s stock after buying an additional 104,588 shares during the quarter. Advisors Asset Management Inc. owned 0.17% of DENTSPLY SIRONA worth $4,429,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Mitsubishi UFJ Trust & Banking Corp lifted its position in DENTSPLY SIRONA by 1,836.7% in the third quarter. Mitsubishi UFJ Trust & Banking Corp now owns 105,938 shares of the medical instruments supplier’s stock valued at $1,344,000 after purchasing an additional 100,468 shares during the last quarter. Bank of Montreal Can grew its holdings in shares of DENTSPLY SIRONA by 8.2% in the second quarter. Bank of Montreal Can now owns 352,524 shares of the medical instruments supplier’s stock worth $5,598,000 after purchasing an additional 26,610 shares during the last quarter. Commonwealth Equity Services LLC increased its stake in shares of DENTSPLY SIRONA by 38.4% in the third quarter. Commonwealth Equity Services LLC now owns 804,934 shares of the medical instruments supplier’s stock worth $10,215,000 after buying an additional 223,339 shares during the period. CWM LLC raised its holdings in DENTSPLY SIRONA by 84.3% during the 3rd quarter. CWM LLC now owns 420,470 shares of the medical instruments supplier’s stock valued at $5,336,000 after buying an additional 192,373 shares during the last quarter. Finally, Nordea Investment Management AB raised its holdings in DENTSPLY SIRONA by 33.3% during the 3rd quarter. Nordea Investment Management AB now owns 570,466 shares of the medical instruments supplier’s stock valued at $7,194,000 after buying an additional 142,451 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.
Analysts Set New Price Targets
XRAY has been the topic of a number of recent analyst reports. Wells Fargo & Company cut their price target on shares of DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating on the stock in a report on Friday, November 7th. Robert W. Baird dropped their target price on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a report on Tuesday, December 16th. Barrington Research reissued an “outperform” rating and issued a $14.00 target price on shares of DENTSPLY SIRONA in a research note on Monday, January 5th. Zacks Research lowered DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a research report on Monday, November 10th. Finally, Wall Street Zen cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday, October 18th. Two equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Reduce” and a consensus target price of $14.25.
Insider Buying and Selling
In other DENTSPLY SIRONA news, Director Gregory T. Lucier sold 82,200 shares of DENTSPLY SIRONA stock in a transaction dated Monday, December 8th. The shares were sold at an average price of $11.14, for a total value of $915,708.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.50% of the company’s stock.
DENTSPLY SIRONA Stock Up 1.1%
NASDAQ:XRAY opened at $12.95 on Friday. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.47 and a quick ratio of 0.99. The firm’s 50-day moving average price is $12.11 and its 200-day moving average price is $12.57. The company has a market capitalization of $2.58 billion, a PE ratio of -2.93, a P/E/G ratio of 1.01 and a beta of 1.01. DENTSPLY SIRONA Inc. has a 1-year low of $9.85 and a 1-year high of $19.27.
DENTSPLY SIRONA Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, January 9th. Investors of record on Friday, December 26th were paid a $0.16 dividend. The ex-dividend date was Friday, December 26th. This represents a $0.64 dividend on an annualized basis and a yield of 4.9%. DENTSPLY SIRONA’s payout ratio is presently -14.48%.
DENTSPLY SIRONA Company Profile
Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.
The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.
See Also
- Five stocks we like better than DENTSPLY SIRONA
- ALERT: Drop these 5 stocks before January 2026!
- The Next Commodity Crunch (bigger than oil?)
- Buy This Stock Now
- Silicon Valley insiders hint at 12-month AI warning
- If You Keep Cash In A U.S. Bank Account… Read This NOW
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.
